Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999
- PMID: 12173140
- DOI: 10.1086/342300
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999
Abstract
We describe the annual incidence of primary bloodstream infection (BSI) associated with Candida albicans and common non-albicans species of Candida among patients in intensive care units that participated in the National Nosocomial Infections Surveillance system from 1 January 1989 through 31 December 1999. During the study period, there was a significant decrease in the incidence of C. albicans BSI (P<.001) and a significant increase in the incidence of Candida glabrata BSI (P=.05).
Similar articles
-
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.Pediatrics. 2006 May;117(5):1680-7. doi: 10.1542/peds.2005-1996. Pediatrics. 2006. PMID: 16651324
-
Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections.Clin Infect Dis. 2008 Jul 15;47(2):e17-24. doi: 10.1086/589298. Clin Infect Dis. 2008. PMID: 18549311
-
Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.Anesth Analg. 2008 Feb;106(2):523-9, table of contents. doi: 10.1213/ane.0b013e3181607262. Anesth Analg. 2008. PMID: 18227310
-
[Epidemiology and prognostic factors of systemic candidiasis in intensive care units].Ann Fr Anesth Reanim. 2001 Apr;20(4):394-9. doi: 10.1016/s0750-7658(01)00370-7. Ann Fr Anesth Reanim. 2001. PMID: 11392252 Review. French.
-
Epidemiology of nosocomial fungal infections, with emphasis on Candida species.Clin Infect Dis. 1995 Jun;20(6):1526-30. doi: 10.1093/clinids/20.6.1526. Clin Infect Dis. 1995. PMID: 7548503 Review.
Cited by
-
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.J Clin Microbiol. 2012 Nov;50(11):3435-42. doi: 10.1128/JCM.01283-12. Epub 2012 Aug 8. J Clin Microbiol. 2012. PMID: 22875889 Free PMC article.
-
Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients.Drugs. 2009;69 Suppl 1:5-14. doi: 10.2165/11315500-000000000-00000. Drugs. 2009. PMID: 19877728 Review.
-
Management of invasive candidiasis in the intensive care unit.Drugs. 2010 May 7;70(7):823-39. doi: 10.2165/10898550-000000000-00000. Drugs. 2010. PMID: 20426495
-
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.J Clin Microbiol. 2004 Apr;42(4):1519-27. doi: 10.1128/JCM.42.4.1519-1527.2004. J Clin Microbiol. 2004. PMID: 15070998 Free PMC article.
-
Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):470-4. doi: 10.1007/s10096-003-0973-8. Epub 2003 Jul 23. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12884068 Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical